November 29th and 30th, 2024
BASL Winter Meeting and Liver Course
Location
Van Diepenbeeckstraat 12, 2018 Antwerpen
Inrit parking
Lamorinièrestraat 53
2018 Antwerpen
Friday 29 November 2024
Liver Course program: Alcohol related liver disease
8.30-9.00 Registration
09.00-10.15 Session 1: HEPATOLOGY UPDATE
Moderators: Thomas Vanwolleghem and Eric Trepo (TBC)
- MASH CPG: update: Elisabetta Bugianesi (University of Torino, Italy)
- Benign Tumours: Jean Charles Nault (Paris Descartes Universite, France)
10.15-10.45 COFFEE BREAK
10.45-12.00 Session 2: NON-INTERACTIVE DISCUSSION OF CLINICAL CASES
Moderators: Filip Janssens and Marie de Vos (TBC)
12.00-12.15 Presentations of BASL YOUNG INVESTIGATORS AWARDS LAUREATES 2024 and short presentation by 2023 Laureates
12.15-12.30 BASL awards for the best clinical and basic publications 2023
(Thomas Vanwolleghem)
12.30-13.30 LUNCH
13.30-15.00 Session 3: Alcohol-related liver disease (first part)
Moderators: Pierre Deltenre and Anja Geerts (TBC)
- Epidemiology and Diagnosis – Peter Stärkel (UCLouvain, Belgium)
- Alcohol use disorder – Philippe De Timary (UCLouvain, Belgium)
- Indications for liver transplantation in alcoholic hepatitis and alcohol-related liver disease and impact of alcohol relapse after transplantation – Philippe Mathurin (University Hospital Lille, France)
15.00-15.15 COFFEE BREAK
15.15-16.45 Session 4: Alcohol-related liver disease (second part)
Moderators: Wim Laleman and Sergio Negrin Dastis (TBC)
- MetALD: How to deal with it? – A Krag (Odense University Hospital, Denmark)
- Home monitoring for patients with decompensated cirrhosis – Raj Mookerjee (University College London, UK)
- Non-oncological palliative care in hepatology – Nathalie Décosterd (Bern, Switzerland)
16.45-17.00 Conclusions and farewell
Saturday 30 November 2024
Liver Course program: Viral hepatitis
8.30-9.00 Registration
9.00-10.45 Session 1: Viral Hepatitis B/D: current and future treatment, special populations
Moderators: Marie Coessens and Pierre Deltenre
- Hepatitis B & D: clinical implications, current treatment
Thomas Vanwolleghem (University of Antwerp) - Hepatitis B: Immunology and future therapeutics
Patrick Kennedy (University of London) - Viral hepatitis in immunocompromised patients and pregnancy
Thomas Sersté (CHU Saint-Pierre/CUB, Brussels)
10.45-11.15 COFFEE BREAK
11.15-13.00 Session 1: Other viral hepatitis infections
Moderators: Sander Lefere and Wim Verlinden
- Hepatitis C
Sergio Negrin-Dastis (Grand Hopital de Charleroi/UCL Saint Luc, Brussels) - Hepatitis A en E: translational insights
Sven Pischke (University of Hamburg) - Clinical importance of non-A-to-E hepatitis (including adenovirus hepatitis in children)
Speaker TBC
13.00 Conclusion and farewell (Sander Lefere, yBASL)